Jing Mm Fu
Research Subjects
Jing Mm Fu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Caisheng Lu
1 shared publication- Markus Y. Mapara
Columbia Center for Translational Immunology, Columbia University, New York, USA
1 shared publication - Meihui Mm Zhang
Department of Respiratory and Critical Care Medicine of Hongqi Hospital Affiliated to Mudanjiang Medical College, Mudanjiang, China
1 shared publication - Minghuan Bd Wang
Department of Stomatology, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, P.R. China
1 shared publication Renzhi Bd Yu
Department of Respiratory and Critical Care Medicine of Hongqi Hospital Affiliated to Mudanjiang Medical College, Mudanjiang, China
1 shared publication- Shahzad Raza
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, USA
1 shared publication
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1 and 2 from Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma
Supplementary Figures 1. Analysis of eIF4E protein levels by western blotting of whole cell extracts from primary stromal cells, CD138- cells, primary myeloma cells (CD138+) and normal plasma cells. Supplementary Figures 2. CT shRNA, eIF4E shRNA, PCDH-GFP or PCDH-eIF4E U266 cells were analyzed by Annexin V binding/ PI staining for apoptotic cells.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1 and 2 from Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma
Supplementary Figures 1. Analysis of eIF4E protein levels by western blotting of whole cell extracts from primary stromal cells, CD138- cells, primary myeloma cells (CD138+) and normal plasma cells. Supplementary Figures 2. CT shRNA, eIF4E shRNA, PCDH-GFP or PCDH-eIF4E U266 cells were analyzed by Annexin V binding/ PI staining for apoptotic cells.
- Open Access
- 16 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (37) , e30569
Effects of high-quality nursing care on quality of life, survival, and recurrence in patients with advanced nonsmall cell lung cancer
Background: Postoperative nursing can improve the quality of life (QoL) and functional prognosis for lung cancer patients. The purpose of this study was to evaluate the effects of high-quality nursing on inflammation and prognosis in postoperative patients with advanced nonsmall cell lung cancer (NSCLC). Methods: A total of 372 patients with NSCLC were enrolled between the May 2014 and June 2016. Patients were randomly received high-quality nursing (n = 192) or normal nursing (n = 180). Symptom management, QoL, hospital stay, inflammatory score, survival time, recurrence rate, symptoms, anxiety, depression scale and psychological distress were assessed at baseline and 5-year follow up. Results: High-quality nursing significantly shortened hospital stay, improved postoperative inflammation, symptom management, QoL compared to patients received normal nursing. Compare with normal nursing, high-quality nursing decreased anxiety, depression scale and psychological distress for postoperative patients with advanced NSCLC. Outcomes showed that high-quality nursing increased the survival time and decreased recurrence rate for postoperative patients with advanced NSCLC. Conclusion: In conclusion, data in the current study indicate that high-quality nursing can decrease inflammation and improve prognosis for the postoperative patients with NSCLC.
- 16 September 2022
- Published by Wolters Kluwer Health in Medicine
- Vol. 101 (37) , e30569
Open AccessEffects of high-quality nursing care on quality of life, survival, and recurrence in patients with advanced nonsmall cell lung cancer
Background: Postoperative nursing can improve the quality of life (QoL) and functional prognosis for lung cancer patients. The purpose of this study was to evaluate the effects of high-quality nursing on inflammation and prognosis in postoperative patients with advanced nonsmall cell lung cancer (NSCLC). Methods: A total of 372 patients with NSCLC were enrolled between the May 2014 and June 2016. Patients were randomly received high-quality nursing (n = 192) or normal nursing (n = 180). Symptom management, QoL, hospital stay, inflammatory score, survival time, recurrence rate, symptoms, anxiety, depression scale and psychological distress were assessed at baseline and 5-year follow up. Results: High-quality nursing significantly shortened hospital stay, improved postoperative inflammation, symptom management, QoL compared to patients received normal nursing. Compare with normal nursing, high-quality nursing decreased anxiety, depression scale and psychological distress for postoperative patients with advanced NSCLC. Outcomes showed that high-quality nursing increased the survival time and decreased recurrence rate for postoperative patients with advanced NSCLC. Conclusion: In conclusion, data in the current study indicate that high-quality nursing can decrease inflammation and improve prognosis for the postoperative patients with NSCLC.